nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CHRM1—epilepsy syndrome	0.0792	0.374	CbGaD
Citalopram—panic disorder—Diazepam—epilepsy syndrome	0.0466	0.138	CpDpCtD
Citalopram—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0429	0.127	CpDpCtD
Citalopram—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0429	0.127	CpDpCtD
Citalopram—SLC6A4—epilepsy syndrome	0.0421	0.199	CbGaD
Citalopram—CYP2C19—epilepsy syndrome	0.0399	0.188	CbGaD
Citalopram—bipolar disorder—Topiramate—epilepsy syndrome	0.0365	0.108	CpDpCtD
Citalopram—endogenous depression—Valproic Acid—epilepsy syndrome	0.0348	0.103	CpDpCtD
Citalopram—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0325	0.0959	CpDpCtD
Citalopram—CYP2D6—epilepsy syndrome	0.0296	0.14	CbGaD
Citalopram—panic disorder—Clonazepam—epilepsy syndrome	0.0283	0.0834	CpDpCtD
Citalopram—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0276	0.0815	CpDpCtD
Citalopram—bipolar disorder—Clonazepam—epilepsy syndrome	0.026	0.0766	CpDpCtD
Citalopram—ABCB1—epilepsy syndrome	0.0211	0.0997	CbGaD
Citalopram—bipolar disorder—Gabapentin—epilepsy syndrome	0.0209	0.0618	CpDpCtD
Citalopram—CYP2E1—Felbamate—epilepsy syndrome	0.00983	0.0376	CbGbCtD
Citalopram—CYP2E1—Trimethadione—epilepsy syndrome	0.00983	0.0376	CbGbCtD
Citalopram—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00912	0.0348	CbGbCtD
Citalopram—CYP2E1—Clonazepam—epilepsy syndrome	0.00836	0.0319	CbGbCtD
Citalopram—CYP2B6—Clobazam—epilepsy syndrome	0.00791	0.0302	CbGbCtD
Citalopram—CYP2E1—Rufinamide—epilepsy syndrome	0.00681	0.026	CbGbCtD
Citalopram—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00663	0.0253	CbGbCtD
Citalopram—CYP2B6—Carbamazepine—epilepsy syndrome	0.00655	0.025	CbGbCtD
Citalopram—CYP2C19—Felbamate—epilepsy syndrome	0.00616	0.0236	CbGbCtD
Citalopram—CYP2C19—Trimethadione—epilepsy syndrome	0.00616	0.0236	CbGbCtD
Citalopram—CYP2B6—Primidone—epilepsy syndrome	0.00612	0.0234	CbGbCtD
Citalopram—CYP2B6—Phenytoin—epilepsy syndrome	0.00588	0.0225	CbGbCtD
Citalopram—ABCB1—Levetiracetam—epilepsy syndrome	0.00585	0.0223	CbGbCtD
Citalopram—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00579	0.0221	CbGbCtD
Citalopram—CYP2E1—Propofol—epilepsy syndrome	0.00556	0.0212	CbGbCtD
Citalopram—CYP2B6—Propofol—epilepsy syndrome	0.00548	0.0209	CbGbCtD
Citalopram—CYP2E1—Phenobarbital—epilepsy syndrome	0.00531	0.0203	CbGbCtD
Citalopram—CYP2B6—Phenobarbital—epilepsy syndrome	0.00524	0.02	CbGbCtD
Citalopram—CYP2E1—Midazolam—epilepsy syndrome	0.00523	0.02	CbGbCtD
Citalopram—CYP2B6—Midazolam—epilepsy syndrome	0.00516	0.0197	CbGbCtD
Citalopram—CYP2E1—Diazepam—epilepsy syndrome	0.00503	0.0192	CbGbCtD
Citalopram—CYP2C19—Clobazam—epilepsy syndrome	0.00502	0.0192	CbGbCtD
Citalopram—CYP2B6—Diazepam—epilepsy syndrome	0.00496	0.019	CbGbCtD
Citalopram—CYP2C19—Carbamazepine—epilepsy syndrome	0.00416	0.0159	CbGbCtD
Citalopram—ABCB1—Clobazam—epilepsy syndrome	0.00405	0.0155	CbGbCtD
Citalopram—CYP2B6—Valproic Acid—epilepsy syndrome	0.00391	0.015	CbGbCtD
Citalopram—ABCB1—Lamotrigine—epilepsy syndrome	0.0039	0.0149	CbGbCtD
Citalopram—CYP2C19—Primidone—epilepsy syndrome	0.00389	0.0149	CbGbCtD
Citalopram—CYP1A2—Carbamazepine—epilepsy syndrome	0.00384	0.0147	CbGbCtD
Citalopram—CYP2C19—Phenytoin—epilepsy syndrome	0.00373	0.0143	CbGbCtD
Citalopram—CYP1A2—Primidone—epilepsy syndrome	0.00359	0.0137	CbGbCtD
Citalopram—CYP2C19—Propofol—epilepsy syndrome	0.00348	0.0133	CbGbCtD
Citalopram—ABCB1—Carbamazepine—epilepsy syndrome	0.00336	0.0128	CbGbCtD
Citalopram—CYP2C19—Phenobarbital—epilepsy syndrome	0.00333	0.0127	CbGbCtD
Citalopram—CYP1A2—Propofol—epilepsy syndrome	0.00321	0.0123	CbGbCtD
Citalopram—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0032	0.0122	CbGbCtD
Citalopram—CYP2C19—Diazepam—epilepsy syndrome	0.00315	0.0121	CbGbCtD
Citalopram—CYP2C19—Zonisamide—epilepsy syndrome	0.00308	0.0118	CbGbCtD
Citalopram—CYP1A2—Phenobarbital—epilepsy syndrome	0.00307	0.0117	CbGbCtD
Citalopram—ABCB1—Phenytoin—epilepsy syndrome	0.00301	0.0115	CbGbCtD
Citalopram—CYP3A4—Felbamate—epilepsy syndrome	0.00298	0.0114	CbGbCtD
Citalopram—CYP3A4—Trimethadione—epilepsy syndrome	0.00298	0.0114	CbGbCtD
Citalopram—CYP1A2—Diazepam—epilepsy syndrome	0.00291	0.0111	CbGbCtD
Citalopram—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0028	0.0107	CbGbCtD
Citalopram—ABCB1—Phenobarbital—epilepsy syndrome	0.00268	0.0103	CbGbCtD
Citalopram—ABCB1—Midazolam—epilepsy syndrome	0.00265	0.0101	CbGbCtD
Citalopram—CYP2D6—Propofol—epilepsy syndrome	0.00265	0.0101	CbGbCtD
Citalopram—ABCB1—Diazepam—epilepsy syndrome	0.00255	0.00973	CbGbCtD
Citalopram—CYP3A4—Clonazepam—epilepsy syndrome	0.00253	0.00968	CbGbCtD
Citalopram—CYP2C19—Valproic Acid—epilepsy syndrome	0.00249	0.0095	CbGbCtD
Citalopram—CYP3A4—Clobazam—epilepsy syndrome	0.00243	0.00928	CbGbCtD
Citalopram—CYP1A2—Valproic Acid—epilepsy syndrome	0.00229	0.00877	CbGbCtD
Citalopram—CYP2C19—Topiramate—epilepsy syndrome	0.00224	0.00857	CbGbCtD
Citalopram—CYP3A4—Rufinamide—epilepsy syndrome	0.00206	0.00789	CbGbCtD
Citalopram—CYP3A4—Carbamazepine—epilepsy syndrome	0.00201	0.00769	CbGbCtD
Citalopram—CYP3A4—Primidone—epilepsy syndrome	0.00188	0.00718	CbGbCtD
Citalopram—CYP3A4—Phenytoin—epilepsy syndrome	0.0018	0.0069	CbGbCtD
Citalopram—SLC6A2—locus ceruleus—epilepsy syndrome	0.0018	0.0869	CbGeAlD
Citalopram—CYP3A4—Propofol—epilepsy syndrome	0.00168	0.00643	CbGbCtD
Citalopram—CYP3A4—Phenobarbital—epilepsy syndrome	0.00161	0.00615	CbGbCtD
Citalopram—CYP3A4—Acetazolamide—epilepsy syndrome	0.00161	0.00615	CbGbCtD
Citalopram—CYP3A4—Midazolam—epilepsy syndrome	0.00159	0.00606	CbGbCtD
Citalopram—CYP3A4—Diazepam—epilepsy syndrome	0.00152	0.00583	CbGbCtD
Citalopram—CYP3A4—Zonisamide—epilepsy syndrome	0.00149	0.00569	CbGbCtD
Citalopram—CYP3A4—Valproic Acid—epilepsy syndrome	0.0012	0.00459	CbGbCtD
Citalopram—CYP3A4—Topiramate—epilepsy syndrome	0.00108	0.00415	CbGbCtD
Citalopram—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00106	0.0511	CbGeAlD
Citalopram—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00102	0.0494	CbGeAlD
Citalopram—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000958	0.0462	CbGeAlD
Citalopram—Escitalopram—CHRM1—epilepsy syndrome	0.000802	0.415	CrCbGaD
Citalopram—SLC6A3—ganglion—epilepsy syndrome	0.00066	0.0318	CbGeAlD
Citalopram—HTR2C—ganglion—epilepsy syndrome	0.000638	0.0307	CbGeAlD
Citalopram—SLC6A4—ganglion—epilepsy syndrome	0.000604	0.0291	CbGeAlD
Citalopram—SLC6A2—ganglion—epilepsy syndrome	0.000532	0.0257	CbGeAlD
Citalopram—SLC6A3—hindbrain—epilepsy syndrome	0.0005	0.0241	CbGeAlD
Citalopram—SLC6A4—hindbrain—epilepsy syndrome	0.000458	0.0221	CbGeAlD
Citalopram—Escitalopram—SLC6A4—epilepsy syndrome	0.000426	0.221	CrCbGaD
Citalopram—Escitalopram—CYP2C19—epilepsy syndrome	0.000404	0.209	CrCbGaD
Citalopram—ADRA1A—hindbrain—epilepsy syndrome	0.000375	0.0181	CbGeAlD
Citalopram—Escitalopram—CYP2D6—epilepsy syndrome	0.000299	0.155	CrCbGaD
Citalopram—SLC6A3—brainstem—epilepsy syndrome	0.000287	0.0138	CbGeAlD
Citalopram—HTR2C—brainstem—epilepsy syndrome	0.000277	0.0134	CbGeAlD
Citalopram—SLC6A3—forebrain—epilepsy syndrome	0.000277	0.0133	CbGeAlD
Citalopram—HTR2C—forebrain—epilepsy syndrome	0.000267	0.0129	CbGeAlD
Citalopram—SLC6A4—brainstem—epilepsy syndrome	0.000263	0.0127	CbGeAlD
Citalopram—SLC6A3—telencephalon—epilepsy syndrome	0.000254	0.0123	CbGeAlD
Citalopram—SLC6A4—forebrain—epilepsy syndrome	0.000254	0.0122	CbGeAlD
Citalopram—CHRM1—forebrain—epilepsy syndrome	0.000253	0.0122	CbGeAlD
Citalopram—HTR2C—telencephalon—epilepsy syndrome	0.000246	0.0119	CbGeAlD
Citalopram—SLC6A4—telencephalon—epilepsy syndrome	0.000233	0.0112	CbGeAlD
Citalopram—CHRM1—telencephalon—epilepsy syndrome	0.000232	0.0112	CbGeAlD
Citalopram—SLC6A2—brainstem—epilepsy syndrome	0.000231	0.0112	CbGeAlD
Citalopram—SLC6A2—forebrain—epilepsy syndrome	0.000223	0.0108	CbGeAlD
Citalopram—CYP2D6—hindbrain—epilepsy syndrome	0.000221	0.0107	CbGeAlD
Citalopram—ADRA1A—brainstem—epilepsy syndrome	0.000215	0.0104	CbGeAlD
Citalopram—ADRA1A—forebrain—epilepsy syndrome	0.000208	0.01	CbGeAlD
Citalopram—SLC6A2—telencephalon—epilepsy syndrome	0.000205	0.0099	CbGeAlD
Citalopram—HTR2C—medulla oblongata—epilepsy syndrome	0.000193	0.00932	CbGeAlD
Citalopram—ADRA1A—telencephalon—epilepsy syndrome	0.000191	0.0092	CbGeAlD
Citalopram—SLC6A3—midbrain—epilepsy syndrome	0.000183	0.00881	CbGeAlD
Citalopram—SLC6A3—spinal cord—epilepsy syndrome	0.000178	0.0086	CbGeAlD
Citalopram—HTR2C—midbrain—epilepsy syndrome	0.000177	0.00852	CbGeAlD
Citalopram—HTR2C—spinal cord—epilepsy syndrome	0.000172	0.00831	CbGeAlD
Citalopram—SLC6A4—midbrain—epilepsy syndrome	0.000167	0.00807	CbGeAlD
Citalopram—SLC6A4—spinal cord—epilepsy syndrome	0.000163	0.00788	CbGeAlD
Citalopram—SLC6A2—medulla oblongata—epilepsy syndrome	0.000161	0.00778	CbGeAlD
Citalopram—HRH1—forebrain—epilepsy syndrome	0.000161	0.00775	CbGeAlD
Citalopram—SLC6A3—head—epilepsy syndrome	0.000158	0.00764	CbGeAlD
Citalopram—HTR2C—head—epilepsy syndrome	0.000153	0.00739	CbGeAlD
Citalopram—SLC6A3—nervous system—epilepsy syndrome	0.00015	0.00724	CbGeAlD
Citalopram—HRH1—telencephalon—epilepsy syndrome	0.000148	0.00712	CbGeAlD
Citalopram—HTR2C—nervous system—epilepsy syndrome	0.000145	0.007	CbGeAlD
Citalopram—SLC6A4—head—epilepsy syndrome	0.000145	0.007	CbGeAlD
Citalopram—CHRM1—head—epilepsy syndrome	0.000145	0.00697	CbGeAlD
Citalopram—SLC6A3—central nervous system—epilepsy syndrome	0.000145	0.00697	CbGeAlD
Citalopram—CYP2E1—telencephalon—epilepsy syndrome	0.000142	0.00684	CbGeAlD
Citalopram—SLC6A3—cerebellum—epilepsy syndrome	0.000141	0.00682	CbGeAlD
Citalopram—HTR2C—central nervous system—epilepsy syndrome	0.00014	0.00674	CbGeAlD
Citalopram—SLC6A4—nervous system—epilepsy syndrome	0.000138	0.00664	CbGeAlD
Citalopram—CHRM1—nervous system—epilepsy syndrome	0.000137	0.00661	CbGeAlD
Citalopram—SLC6A4—central nervous system—epilepsy syndrome	0.000133	0.00639	CbGeAlD
Citalopram—CHRM1—central nervous system—epilepsy syndrome	0.000132	0.00637	CbGeAlD
Citalopram—SLC6A2—head—epilepsy syndrome	0.000128	0.00616	CbGeAlD
Citalopram—CYP2D6—brainstem—epilepsy syndrome	0.000127	0.00611	CbGeAlD
Citalopram—CYP2D6—forebrain—epilepsy syndrome	0.000122	0.00589	CbGeAlD
Citalopram—SLC6A2—nervous system—epilepsy syndrome	0.000121	0.00584	CbGeAlD
Citalopram—ADRA1A—head—epilepsy syndrome	0.000119	0.00573	CbGeAlD
Citalopram—SLC6A2—central nervous system—epilepsy syndrome	0.000117	0.00563	CbGeAlD
Citalopram—SLC6A3—brain—epilepsy syndrome	0.000115	0.00554	CbGeAlD
Citalopram—ADRA1A—nervous system—epilepsy syndrome	0.000113	0.00543	CbGeAlD
Citalopram—CYP2D6—telencephalon—epilepsy syndrome	0.000112	0.00542	CbGeAlD
Citalopram—CYP2E1—medulla oblongata—epilepsy syndrome	0.000112	0.00538	CbGeAlD
Citalopram—HTR2C—brain—epilepsy syndrome	0.000111	0.00535	CbGeAlD
Citalopram—ADRA1A—central nervous system—epilepsy syndrome	0.000108	0.00523	CbGeAlD
Citalopram—ADRA1A—cerebellum—epilepsy syndrome	0.000106	0.00511	CbGeAlD
Citalopram—SLC6A4—brain—epilepsy syndrome	0.000105	0.00507	CbGeAlD
Citalopram—CHRM1—brain—epilepsy syndrome	0.000105	0.00505	CbGeAlD
Citalopram—CYP2E1—spinal cord—epilepsy syndrome	9.95e-05	0.0048	CbGeAlD
Citalopram—CYP2B6—head—epilepsy syndrome	9.42e-05	0.00454	CbGeAlD
Citalopram—SLC6A2—brain—epilepsy syndrome	9.26e-05	0.00447	CbGeAlD
Citalopram—HRH1—head—epilepsy syndrome	9.2e-05	0.00444	CbGeAlD
Citalopram—CYP2B6—nervous system—epilepsy syndrome	8.93e-05	0.00431	CbGeAlD
Citalopram—CYP2E1—head—epilepsy syndrome	8.84e-05	0.00426	CbGeAlD
Citalopram—ABCB1—forebrain—epilepsy syndrome	8.79e-05	0.00424	CbGeAlD
Citalopram—HRH1—nervous system—epilepsy syndrome	8.72e-05	0.00421	CbGeAlD
Citalopram—ADRA1A—brain—epilepsy syndrome	8.61e-05	0.00415	CbGeAlD
Citalopram—CYP2B6—central nervous system—epilepsy syndrome	8.6e-05	0.00415	CbGeAlD
Citalopram—HRH1—central nervous system—epilepsy syndrome	8.4e-05	0.00405	CbGeAlD
Citalopram—CYP2E1—nervous system—epilepsy syndrome	8.38e-05	0.00404	CbGeAlD
Citalopram—ABCB1—telencephalon—epilepsy syndrome	8.09e-05	0.0039	CbGeAlD
Citalopram—CYP2E1—central nervous system—epilepsy syndrome	8.07e-05	0.00389	CbGeAlD
Citalopram—CYP2E1—cerebellum—epilepsy syndrome	7.89e-05	0.0038	CbGeAlD
Citalopram—CYP2D6—head—epilepsy syndrome	7e-05	0.00337	CbGeAlD
Citalopram—CYP2B6—brain—epilepsy syndrome	6.83e-05	0.00329	CbGeAlD
Citalopram—CYP3A4—nervous system—epilepsy syndrome	6.74e-05	0.00325	CbGeAlD
Citalopram—HRH1—brain—epilepsy syndrome	6.67e-05	0.00321	CbGeAlD
Citalopram—CYP2D6—nervous system—epilepsy syndrome	6.64e-05	0.0032	CbGeAlD
Citalopram—CYP3A4—central nervous system—epilepsy syndrome	6.49e-05	0.00313	CbGeAlD
Citalopram—CYP2E1—brain—epilepsy syndrome	6.41e-05	0.00309	CbGeAlD
Citalopram—CYP2D6—central nervous system—epilepsy syndrome	6.39e-05	0.00308	CbGeAlD
Citalopram—ABCB1—medulla oblongata—epilepsy syndrome	6.35e-05	0.00306	CbGeAlD
Citalopram—CYP2D6—cerebellum—epilepsy syndrome	6.24e-05	0.00301	CbGeAlD
Citalopram—ABCB1—midbrain—epilepsy syndrome	5.81e-05	0.0028	CbGeAlD
Citalopram—ABCB1—spinal cord—epilepsy syndrome	5.67e-05	0.00273	CbGeAlD
Citalopram—CYP2D6—brain—epilepsy syndrome	5.07e-05	0.00245	CbGeAlD
Citalopram—ABCB1—head—epilepsy syndrome	5.04e-05	0.00243	CbGeAlD
Citalopram—ABCB1—nervous system—epilepsy syndrome	4.77e-05	0.0023	CbGeAlD
Citalopram—ABCB1—central nervous system—epilepsy syndrome	4.6e-05	0.00222	CbGeAlD
Citalopram—ABCB1—cerebellum—epilepsy syndrome	4.49e-05	0.00217	CbGeAlD
Citalopram—ABCB1—brain—epilepsy syndrome	3.65e-05	0.00176	CbGeAlD
Citalopram—Asthenia—Carbamazepine—epilepsy syndrome	7.37e-06	5.95e-05	CcSEcCtD
Citalopram—Agitation—Gabapentin—epilepsy syndrome	7.37e-06	5.94e-05	CcSEcCtD
Citalopram—Diarrhoea—Phenytoin—epilepsy syndrome	7.37e-06	5.94e-05	CcSEcCtD
Citalopram—Discomfort—Pregabalin—epilepsy syndrome	7.35e-06	5.93e-05	CcSEcCtD
Citalopram—Nausea—Fosphenytoin—epilepsy syndrome	7.35e-06	5.93e-05	CcSEcCtD
Citalopram—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.33e-06	5.91e-05	CcSEcCtD
Citalopram—Erythema multiforme—Topiramate—epilepsy syndrome	7.32e-06	5.91e-05	CcSEcCtD
Citalopram—Angioedema—Gabapentin—epilepsy syndrome	7.32e-06	5.91e-05	CcSEcCtD
Citalopram—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.32e-06	5.9e-05	CcSEcCtD
Citalopram—Vomiting—Felbamate—epilepsy syndrome	7.3e-06	5.89e-05	CcSEcCtD
Citalopram—Dry mouth—Pregabalin—epilepsy syndrome	7.28e-06	5.87e-05	CcSEcCtD
Citalopram—Pruritus—Carbamazepine—epilepsy syndrome	7.27e-06	5.86e-05	CcSEcCtD
Citalopram—Rash—Felbamate—epilepsy syndrome	7.24e-06	5.84e-05	CcSEcCtD
Citalopram—Eye disorder—Topiramate—epilepsy syndrome	7.24e-06	5.84e-05	CcSEcCtD
Citalopram—Dermatitis—Felbamate—epilepsy syndrome	7.24e-06	5.84e-05	CcSEcCtD
Citalopram—Malaise—Gabapentin—epilepsy syndrome	7.23e-06	5.83e-05	CcSEcCtD
Citalopram—Tinnitus—Topiramate—epilepsy syndrome	7.22e-06	5.83e-05	CcSEcCtD
Citalopram—Vertigo—Gabapentin—epilepsy syndrome	7.2e-06	5.81e-05	CcSEcCtD
Citalopram—Headache—Felbamate—epilepsy syndrome	7.2e-06	5.8e-05	CcSEcCtD
Citalopram—Confusional state—Pregabalin—epilepsy syndrome	7.19e-06	5.8e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.19e-06	5.8e-05	CcSEcCtD
Citalopram—Cardiac disorder—Topiramate—epilepsy syndrome	7.19e-06	5.8e-05	CcSEcCtD
Citalopram—Flushing—Topiramate—epilepsy syndrome	7.19e-06	5.8e-05	CcSEcCtD
Citalopram—Syncope—Gabapentin—epilepsy syndrome	7.19e-06	5.8e-05	CcSEcCtD
Citalopram—Leukopenia—Gabapentin—epilepsy syndrome	7.17e-06	5.79e-05	CcSEcCtD
Citalopram—Dizziness—Clonazepam—epilepsy syndrome	7.17e-06	5.78e-05	CcSEcCtD
Citalopram—Nausea—Vigabatrin—epilepsy syndrome	7.16e-06	5.78e-05	CcSEcCtD
Citalopram—Vomiting—Zonisamide—epilepsy syndrome	7.15e-06	5.77e-05	CcSEcCtD
Citalopram—Insomnia—Valproic Acid—epilepsy syndrome	7.14e-06	5.76e-05	CcSEcCtD
Citalopram—Oedema—Pregabalin—epilepsy syndrome	7.13e-06	5.75e-05	CcSEcCtD
Citalopram—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.13e-06	5.75e-05	CcSEcCtD
Citalopram—Asthenia—Lamotrigine—epilepsy syndrome	7.13e-06	5.75e-05	CcSEcCtD
Citalopram—Dizziness—Phenytoin—epilepsy syndrome	7.12e-06	5.74e-05	CcSEcCtD
Citalopram—Rash—Zonisamide—epilepsy syndrome	7.09e-06	5.72e-05	CcSEcCtD
Citalopram—Infection—Pregabalin—epilepsy syndrome	7.09e-06	5.72e-05	CcSEcCtD
Citalopram—Paraesthesia—Valproic Acid—epilepsy syndrome	7.09e-06	5.71e-05	CcSEcCtD
Citalopram—Palpitations—Gabapentin—epilepsy syndrome	7.08e-06	5.71e-05	CcSEcCtD
Citalopram—Dermatitis—Zonisamide—epilepsy syndrome	7.08e-06	5.71e-05	CcSEcCtD
Citalopram—Dizziness—Oxcarbazepine—epilepsy syndrome	7.08e-06	5.71e-05	CcSEcCtD
Citalopram—Nausea—Diazepam—epilepsy syndrome	7.05e-06	5.69e-05	CcSEcCtD
Citalopram—Loss of consciousness—Gabapentin—epilepsy syndrome	7.05e-06	5.68e-05	CcSEcCtD
Citalopram—Headache—Zonisamide—epilepsy syndrome	7.04e-06	5.68e-05	CcSEcCtD
Citalopram—Dyspnoea—Valproic Acid—epilepsy syndrome	7.04e-06	5.67e-05	CcSEcCtD
Citalopram—Diarrhoea—Carbamazepine—epilepsy syndrome	7.03e-06	5.67e-05	CcSEcCtD
Citalopram—Angiopathy—Topiramate—epilepsy syndrome	7.03e-06	5.67e-05	CcSEcCtD
Citalopram—Pruritus—Lamotrigine—epilepsy syndrome	7.03e-06	5.67e-05	CcSEcCtD
Citalopram—Shock—Pregabalin—epilepsy syndrome	7.02e-06	5.66e-05	CcSEcCtD
Citalopram—Somnolence—Valproic Acid—epilepsy syndrome	7.02e-06	5.66e-05	CcSEcCtD
Citalopram—Immune system disorder—Topiramate—epilepsy syndrome	7e-06	5.64e-05	CcSEcCtD
Citalopram—Nervous system disorder—Pregabalin—epilepsy syndrome	7e-06	5.64e-05	CcSEcCtD
Citalopram—Cough—Gabapentin—epilepsy syndrome	6.99e-06	5.64e-05	CcSEcCtD
Citalopram—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.99e-06	5.63e-05	CcSEcCtD
Citalopram—Mediastinal disorder—Topiramate—epilepsy syndrome	6.98e-06	5.63e-05	CcSEcCtD
Citalopram—Tachycardia—Pregabalin—epilepsy syndrome	6.96e-06	5.62e-05	CcSEcCtD
Citalopram—Chills—Topiramate—epilepsy syndrome	6.95e-06	5.61e-05	CcSEcCtD
Citalopram—Dyspepsia—Valproic Acid—epilepsy syndrome	6.95e-06	5.6e-05	CcSEcCtD
Citalopram—Convulsion—Gabapentin—epilepsy syndrome	6.94e-06	5.6e-05	CcSEcCtD
Citalopram—Skin disorder—Pregabalin—epilepsy syndrome	6.93e-06	5.59e-05	CcSEcCtD
Citalopram—Hypertension—Gabapentin—epilepsy syndrome	6.92e-06	5.58e-05	CcSEcCtD
Citalopram—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.9e-06	5.56e-05	CcSEcCtD
Citalopram—Vomiting—Clonazepam—epilepsy syndrome	6.89e-06	5.56e-05	CcSEcCtD
Citalopram—Decreased appetite—Valproic Acid—epilepsy syndrome	6.86e-06	5.53e-05	CcSEcCtD
Citalopram—Alopecia—Topiramate—epilepsy syndrome	6.85e-06	5.52e-05	CcSEcCtD
Citalopram—Vomiting—Phenytoin—epilepsy syndrome	6.84e-06	5.52e-05	CcSEcCtD
Citalopram—Rash—Clonazepam—epilepsy syndrome	6.83e-06	5.51e-05	CcSEcCtD
Citalopram—Dermatitis—Clonazepam—epilepsy syndrome	6.83e-06	5.51e-05	CcSEcCtD
Citalopram—Chest pain—Gabapentin—epilepsy syndrome	6.82e-06	5.5e-05	CcSEcCtD
Citalopram—Myalgia—Gabapentin—epilepsy syndrome	6.82e-06	5.5e-05	CcSEcCtD
Citalopram—Arthralgia—Gabapentin—epilepsy syndrome	6.82e-06	5.5e-05	CcSEcCtD
Citalopram—Nausea—Felbamate—epilepsy syndrome	6.82e-06	5.5e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.81e-06	5.49e-05	CcSEcCtD
Citalopram—Vomiting—Oxcarbazepine—epilepsy syndrome	6.81e-06	5.49e-05	CcSEcCtD
Citalopram—Fatigue—Valproic Acid—epilepsy syndrome	6.8e-06	5.49e-05	CcSEcCtD
Citalopram—Anxiety—Gabapentin—epilepsy syndrome	6.8e-06	5.48e-05	CcSEcCtD
Citalopram—Anorexia—Pregabalin—epilepsy syndrome	6.8e-06	5.48e-05	CcSEcCtD
Citalopram—Dizziness—Carbamazepine—epilepsy syndrome	6.79e-06	5.48e-05	CcSEcCtD
Citalopram—Diarrhoea—Lamotrigine—epilepsy syndrome	6.79e-06	5.48e-05	CcSEcCtD
Citalopram—Headache—Clonazepam—epilepsy syndrome	6.79e-06	5.48e-05	CcSEcCtD
Citalopram—Rash—Phenytoin—epilepsy syndrome	6.79e-06	5.47e-05	CcSEcCtD
Citalopram—Mental disorder—Topiramate—epilepsy syndrome	6.79e-06	5.47e-05	CcSEcCtD
Citalopram—Dermatitis—Phenytoin—epilepsy syndrome	6.78e-06	5.47e-05	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.78e-06	5.47e-05	CcSEcCtD
Citalopram—Rash—Oxcarbazepine—epilepsy syndrome	6.75e-06	5.45e-05	CcSEcCtD
Citalopram—Constipation—Valproic Acid—epilepsy syndrome	6.75e-06	5.44e-05	CcSEcCtD
Citalopram—Pain—Valproic Acid—epilepsy syndrome	6.75e-06	5.44e-05	CcSEcCtD
Citalopram—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.75e-06	5.44e-05	CcSEcCtD
Citalopram—Headache—Phenytoin—epilepsy syndrome	6.74e-06	5.44e-05	CcSEcCtD
Citalopram—Malnutrition—Topiramate—epilepsy syndrome	6.74e-06	5.44e-05	CcSEcCtD
Citalopram—Erythema—Topiramate—epilepsy syndrome	6.74e-06	5.44e-05	CcSEcCtD
Citalopram—Discomfort—Gabapentin—epilepsy syndrome	6.74e-06	5.44e-05	CcSEcCtD
Citalopram—Headache—Oxcarbazepine—epilepsy syndrome	6.71e-06	5.41e-05	CcSEcCtD
Citalopram—Nausea—Zonisamide—epilepsy syndrome	6.68e-06	5.39e-05	CcSEcCtD
Citalopram—Dry mouth—Gabapentin—epilepsy syndrome	6.67e-06	5.38e-05	CcSEcCtD
Citalopram—Hypotension—Pregabalin—epilepsy syndrome	6.67e-06	5.38e-05	CcSEcCtD
Citalopram—Flatulence—Topiramate—epilepsy syndrome	6.65e-06	5.36e-05	CcSEcCtD
Citalopram—Tension—Topiramate—epilepsy syndrome	6.62e-06	5.34e-05	CcSEcCtD
Citalopram—Dysgeusia—Topiramate—epilepsy syndrome	6.6e-06	5.33e-05	CcSEcCtD
Citalopram—Confusional state—Gabapentin—epilepsy syndrome	6.6e-06	5.32e-05	CcSEcCtD
Citalopram—Dizziness—Lamotrigine—epilepsy syndrome	6.57e-06	5.3e-05	CcSEcCtD
Citalopram—Nervousness—Topiramate—epilepsy syndrome	6.55e-06	5.28e-05	CcSEcCtD
Citalopram—Oedema—Gabapentin—epilepsy syndrome	6.54e-06	5.28e-05	CcSEcCtD
Citalopram—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.54e-06	5.28e-05	CcSEcCtD
Citalopram—Vomiting—Carbamazepine—epilepsy syndrome	6.53e-06	5.27e-05	CcSEcCtD
Citalopram—Back pain—Topiramate—epilepsy syndrome	6.52e-06	5.26e-05	CcSEcCtD
Citalopram—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.5e-06	5.24e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.5e-06	5.24e-05	CcSEcCtD
Citalopram—Infection—Gabapentin—epilepsy syndrome	6.5e-06	5.24e-05	CcSEcCtD
Citalopram—Muscle spasms—Topiramate—epilepsy syndrome	6.48e-06	5.23e-05	CcSEcCtD
Citalopram—Rash—Carbamazepine—epilepsy syndrome	6.48e-06	5.23e-05	CcSEcCtD
Citalopram—Dermatitis—Carbamazepine—epilepsy syndrome	6.47e-06	5.22e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.45e-06	5.2e-05	CcSEcCtD
Citalopram—Insomnia—Pregabalin—epilepsy syndrome	6.45e-06	5.2e-05	CcSEcCtD
Citalopram—Nausea—Clonazepam—epilepsy syndrome	6.44e-06	5.19e-05	CcSEcCtD
Citalopram—Headache—Carbamazepine—epilepsy syndrome	6.44e-06	5.19e-05	CcSEcCtD
Citalopram—Shock—Gabapentin—epilepsy syndrome	6.44e-06	5.19e-05	CcSEcCtD
Citalopram—Nervous system disorder—Gabapentin—epilepsy syndrome	6.42e-06	5.17e-05	CcSEcCtD
Citalopram—Paraesthesia—Pregabalin—epilepsy syndrome	6.41e-06	5.17e-05	CcSEcCtD
Citalopram—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.41e-06	5.17e-05	CcSEcCtD
Citalopram—Nausea—Phenytoin—epilepsy syndrome	6.39e-06	5.16e-05	CcSEcCtD
Citalopram—Tachycardia—Gabapentin—epilepsy syndrome	6.38e-06	5.15e-05	CcSEcCtD
Citalopram—Dyspnoea—Pregabalin—epilepsy syndrome	6.36e-06	5.13e-05	CcSEcCtD
Citalopram—Nausea—Oxcarbazepine—epilepsy syndrome	6.36e-06	5.13e-05	CcSEcCtD
Citalopram—Vision blurred—Topiramate—epilepsy syndrome	6.36e-06	5.13e-05	CcSEcCtD
Citalopram—Skin disorder—Gabapentin—epilepsy syndrome	6.35e-06	5.12e-05	CcSEcCtD
Citalopram—Somnolence—Pregabalin—epilepsy syndrome	6.34e-06	5.12e-05	CcSEcCtD
Citalopram—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.32e-06	5.1e-05	CcSEcCtD
Citalopram—Tremor—Topiramate—epilepsy syndrome	6.32e-06	5.1e-05	CcSEcCtD
Citalopram—Vomiting—Lamotrigine—epilepsy syndrome	6.31e-06	5.09e-05	CcSEcCtD
Citalopram—Urticaria—Valproic Acid—epilepsy syndrome	6.27e-06	5.06e-05	CcSEcCtD
Citalopram—Rash—Lamotrigine—epilepsy syndrome	6.26e-06	5.05e-05	CcSEcCtD
Citalopram—Ill-defined disorder—Topiramate—epilepsy syndrome	6.26e-06	5.05e-05	CcSEcCtD
Citalopram—Dermatitis—Lamotrigine—epilepsy syndrome	6.26e-06	5.05e-05	CcSEcCtD
Citalopram—Abdominal pain—Valproic Acid—epilepsy syndrome	6.24e-06	5.03e-05	CcSEcCtD
Citalopram—Body temperature increased—Valproic Acid—epilepsy syndrome	6.24e-06	5.03e-05	CcSEcCtD
Citalopram—Anorexia—Gabapentin—epilepsy syndrome	6.24e-06	5.03e-05	CcSEcCtD
Citalopram—Anaemia—Topiramate—epilepsy syndrome	6.23e-06	5.03e-05	CcSEcCtD
Citalopram—Headache—Lamotrigine—epilepsy syndrome	6.22e-06	5.02e-05	CcSEcCtD
Citalopram—Decreased appetite—Pregabalin—epilepsy syndrome	6.2e-06	5e-05	CcSEcCtD
Citalopram—Agitation—Topiramate—epilepsy syndrome	6.2e-06	5e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.16e-06	4.97e-05	CcSEcCtD
Citalopram—Fatigue—Pregabalin—epilepsy syndrome	6.15e-06	4.96e-05	CcSEcCtD
Citalopram—Hypotension—Gabapentin—epilepsy syndrome	6.11e-06	4.93e-05	CcSEcCtD
Citalopram—Nausea—Carbamazepine—epilepsy syndrome	6.1e-06	4.92e-05	CcSEcCtD
Citalopram—Constipation—Pregabalin—epilepsy syndrome	6.1e-06	4.92e-05	CcSEcCtD
Citalopram—Pain—Pregabalin—epilepsy syndrome	6.1e-06	4.92e-05	CcSEcCtD
Citalopram—Malaise—Topiramate—epilepsy syndrome	6.08e-06	4.9e-05	CcSEcCtD
Citalopram—Vertigo—Topiramate—epilepsy syndrome	6.06e-06	4.89e-05	CcSEcCtD
Citalopram—Syncope—Topiramate—epilepsy syndrome	6.05e-06	4.88e-05	CcSEcCtD
Citalopram—Leukopenia—Topiramate—epilepsy syndrome	6.04e-06	4.87e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.96e-06	4.81e-05	CcSEcCtD
Citalopram—Palpitations—Topiramate—epilepsy syndrome	5.96e-06	4.81e-05	CcSEcCtD
Citalopram—Loss of consciousness—Topiramate—epilepsy syndrome	5.93e-06	4.78e-05	CcSEcCtD
Citalopram—Insomnia—Gabapentin—epilepsy syndrome	5.92e-06	4.77e-05	CcSEcCtD
Citalopram—Nausea—Lamotrigine—epilepsy syndrome	5.9e-06	4.76e-05	CcSEcCtD
Citalopram—Cough—Topiramate—epilepsy syndrome	5.88e-06	4.75e-05	CcSEcCtD
Citalopram—Feeling abnormal—Pregabalin—epilepsy syndrome	5.88e-06	4.74e-05	CcSEcCtD
Citalopram—Paraesthesia—Gabapentin—epilepsy syndrome	5.87e-06	4.74e-05	CcSEcCtD
Citalopram—Convulsion—Topiramate—epilepsy syndrome	5.84e-06	4.71e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.83e-06	4.7e-05	CcSEcCtD
Citalopram—Dyspnoea—Gabapentin—epilepsy syndrome	5.83e-06	4.7e-05	CcSEcCtD
Citalopram—Hypertension—Topiramate—epilepsy syndrome	5.82e-06	4.7e-05	CcSEcCtD
Citalopram—Somnolence—Gabapentin—epilepsy syndrome	5.82e-06	4.69e-05	CcSEcCtD
Citalopram—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.81e-06	4.69e-05	CcSEcCtD
Citalopram—Dyspepsia—Gabapentin—epilepsy syndrome	5.76e-06	4.64e-05	CcSEcCtD
Citalopram—Chest pain—Topiramate—epilepsy syndrome	5.74e-06	4.63e-05	CcSEcCtD
Citalopram—Arthralgia—Topiramate—epilepsy syndrome	5.74e-06	4.63e-05	CcSEcCtD
Citalopram—Myalgia—Topiramate—epilepsy syndrome	5.74e-06	4.63e-05	CcSEcCtD
Citalopram—Anxiety—Topiramate—epilepsy syndrome	5.72e-06	4.61e-05	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.7e-06	4.6e-05	CcSEcCtD
Citalopram—Decreased appetite—Gabapentin—epilepsy syndrome	5.69e-06	4.59e-05	CcSEcCtD
Citalopram—Discomfort—Topiramate—epilepsy syndrome	5.67e-06	4.57e-05	CcSEcCtD
Citalopram—Urticaria—Pregabalin—epilepsy syndrome	5.67e-06	4.57e-05	CcSEcCtD
Citalopram—Asthenia—Valproic Acid—epilepsy syndrome	5.66e-06	4.57e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.65e-06	4.55e-05	CcSEcCtD
Citalopram—Fatigue—Gabapentin—epilepsy syndrome	5.64e-06	4.55e-05	CcSEcCtD
Citalopram—Abdominal pain—Pregabalin—epilepsy syndrome	5.64e-06	4.55e-05	CcSEcCtD
Citalopram—Body temperature increased—Pregabalin—epilepsy syndrome	5.64e-06	4.55e-05	CcSEcCtD
Citalopram—Dry mouth—Topiramate—epilepsy syndrome	5.61e-06	4.53e-05	CcSEcCtD
Citalopram—Pain—Gabapentin—epilepsy syndrome	5.59e-06	4.51e-05	CcSEcCtD
Citalopram—Constipation—Gabapentin—epilepsy syndrome	5.59e-06	4.51e-05	CcSEcCtD
Citalopram—Pruritus—Valproic Acid—epilepsy syndrome	5.58e-06	4.5e-05	CcSEcCtD
Citalopram—Confusional state—Topiramate—epilepsy syndrome	5.55e-06	4.48e-05	CcSEcCtD
Citalopram—Oedema—Topiramate—epilepsy syndrome	5.5e-06	4.44e-05	CcSEcCtD
Citalopram—Infection—Topiramate—epilepsy syndrome	5.47e-06	4.41e-05	CcSEcCtD
Citalopram—Shock—Topiramate—epilepsy syndrome	5.41e-06	4.37e-05	CcSEcCtD
Citalopram—Diarrhoea—Valproic Acid—epilepsy syndrome	5.4e-06	4.35e-05	CcSEcCtD
Citalopram—Nervous system disorder—Topiramate—epilepsy syndrome	5.4e-06	4.35e-05	CcSEcCtD
Citalopram—Feeling abnormal—Gabapentin—epilepsy syndrome	5.39e-06	4.35e-05	CcSEcCtD
Citalopram—Thrombocytopenia—Topiramate—epilepsy syndrome	5.39e-06	4.35e-05	CcSEcCtD
Citalopram—Tachycardia—Topiramate—epilepsy syndrome	5.37e-06	4.33e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.35e-06	4.31e-05	CcSEcCtD
Citalopram—Skin disorder—Topiramate—epilepsy syndrome	5.35e-06	4.31e-05	CcSEcCtD
Citalopram—Hyperhidrosis—Topiramate—epilepsy syndrome	5.32e-06	4.29e-05	CcSEcCtD
Citalopram—Hypersensitivity—Pregabalin—epilepsy syndrome	5.26e-06	4.24e-05	CcSEcCtD
Citalopram—Anorexia—Topiramate—epilepsy syndrome	5.25e-06	4.23e-05	CcSEcCtD
Citalopram—Dizziness—Valproic Acid—epilepsy syndrome	5.22e-06	4.21e-05	CcSEcCtD
Citalopram—Urticaria—Gabapentin—epilepsy syndrome	5.2e-06	4.19e-05	CcSEcCtD
Citalopram—Abdominal pain—Gabapentin—epilepsy syndrome	5.17e-06	4.17e-05	CcSEcCtD
Citalopram—Body temperature increased—Gabapentin—epilepsy syndrome	5.17e-06	4.17e-05	CcSEcCtD
Citalopram—Hypotension—Topiramate—epilepsy syndrome	5.14e-06	4.15e-05	CcSEcCtD
Citalopram—Asthenia—Pregabalin—epilepsy syndrome	5.12e-06	4.13e-05	CcSEcCtD
Citalopram—Pruritus—Pregabalin—epilepsy syndrome	5.05e-06	4.07e-05	CcSEcCtD
Citalopram—Vomiting—Valproic Acid—epilepsy syndrome	5.02e-06	4.05e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.01e-06	4.04e-05	CcSEcCtD
Citalopram—Insomnia—Topiramate—epilepsy syndrome	4.98e-06	4.01e-05	CcSEcCtD
Citalopram—Rash—Valproic Acid—epilepsy syndrome	4.98e-06	4.01e-05	CcSEcCtD
Citalopram—Dermatitis—Valproic Acid—epilepsy syndrome	4.97e-06	4.01e-05	CcSEcCtD
Citalopram—Headache—Valproic Acid—epilepsy syndrome	4.94e-06	3.99e-05	CcSEcCtD
Citalopram—Paraesthesia—Topiramate—epilepsy syndrome	4.94e-06	3.99e-05	CcSEcCtD
Citalopram—Dyspnoea—Topiramate—epilepsy syndrome	4.91e-06	3.96e-05	CcSEcCtD
Citalopram—Somnolence—Topiramate—epilepsy syndrome	4.89e-06	3.95e-05	CcSEcCtD
Citalopram—Diarrhoea—Pregabalin—epilepsy syndrome	4.88e-06	3.94e-05	CcSEcCtD
Citalopram—Dyspepsia—Topiramate—epilepsy syndrome	4.84e-06	3.91e-05	CcSEcCtD
Citalopram—Hypersensitivity—Gabapentin—epilepsy syndrome	4.82e-06	3.89e-05	CcSEcCtD
Citalopram—Decreased appetite—Topiramate—epilepsy syndrome	4.78e-06	3.86e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.75e-06	3.83e-05	CcSEcCtD
Citalopram—Fatigue—Topiramate—epilepsy syndrome	4.75e-06	3.83e-05	CcSEcCtD
Citalopram—Dizziness—Pregabalin—epilepsy syndrome	4.72e-06	3.8e-05	CcSEcCtD
Citalopram—Constipation—Topiramate—epilepsy syndrome	4.71e-06	3.8e-05	CcSEcCtD
Citalopram—Pain—Topiramate—epilepsy syndrome	4.71e-06	3.8e-05	CcSEcCtD
Citalopram—Asthenia—Gabapentin—epilepsy syndrome	4.69e-06	3.79e-05	CcSEcCtD
Citalopram—Nausea—Valproic Acid—epilepsy syndrome	4.69e-06	3.78e-05	CcSEcCtD
Citalopram—Pruritus—Gabapentin—epilepsy syndrome	4.63e-06	3.73e-05	CcSEcCtD
Citalopram—Vomiting—Pregabalin—epilepsy syndrome	4.54e-06	3.66e-05	CcSEcCtD
Citalopram—Feeling abnormal—Topiramate—epilepsy syndrome	4.54e-06	3.66e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.5e-06	3.63e-05	CcSEcCtD
Citalopram—Rash—Pregabalin—epilepsy syndrome	4.5e-06	3.63e-05	CcSEcCtD
Citalopram—Dermatitis—Pregabalin—epilepsy syndrome	4.49e-06	3.62e-05	CcSEcCtD
Citalopram—Diarrhoea—Gabapentin—epilepsy syndrome	4.48e-06	3.61e-05	CcSEcCtD
Citalopram—Headache—Pregabalin—epilepsy syndrome	4.47e-06	3.6e-05	CcSEcCtD
Citalopram—Urticaria—Topiramate—epilepsy syndrome	4.37e-06	3.53e-05	CcSEcCtD
Citalopram—Abdominal pain—Topiramate—epilepsy syndrome	4.35e-06	3.51e-05	CcSEcCtD
Citalopram—Body temperature increased—Topiramate—epilepsy syndrome	4.35e-06	3.51e-05	CcSEcCtD
Citalopram—Dizziness—Gabapentin—epilepsy syndrome	4.33e-06	3.49e-05	CcSEcCtD
Citalopram—Nausea—Pregabalin—epilepsy syndrome	4.24e-06	3.42e-05	CcSEcCtD
Citalopram—Vomiting—Gabapentin—epilepsy syndrome	4.16e-06	3.35e-05	CcSEcCtD
Citalopram—Rash—Gabapentin—epilepsy syndrome	4.12e-06	3.33e-05	CcSEcCtD
Citalopram—Dermatitis—Gabapentin—epilepsy syndrome	4.12e-06	3.32e-05	CcSEcCtD
Citalopram—Headache—Gabapentin—epilepsy syndrome	4.1e-06	3.31e-05	CcSEcCtD
Citalopram—Hypersensitivity—Topiramate—epilepsy syndrome	4.05e-06	3.27e-05	CcSEcCtD
Citalopram—Asthenia—Topiramate—epilepsy syndrome	3.95e-06	3.18e-05	CcSEcCtD
Citalopram—Pruritus—Topiramate—epilepsy syndrome	3.89e-06	3.14e-05	CcSEcCtD
Citalopram—Nausea—Gabapentin—epilepsy syndrome	3.89e-06	3.13e-05	CcSEcCtD
Citalopram—Diarrhoea—Topiramate—epilepsy syndrome	3.77e-06	3.04e-05	CcSEcCtD
Citalopram—Dizziness—Topiramate—epilepsy syndrome	3.64e-06	2.94e-05	CcSEcCtD
Citalopram—Vomiting—Topiramate—epilepsy syndrome	3.5e-06	2.82e-05	CcSEcCtD
Citalopram—Rash—Topiramate—epilepsy syndrome	3.47e-06	2.8e-05	CcSEcCtD
Citalopram—Dermatitis—Topiramate—epilepsy syndrome	3.47e-06	2.8e-05	CcSEcCtD
Citalopram—Headache—Topiramate—epilepsy syndrome	3.45e-06	2.78e-05	CcSEcCtD
Citalopram—Nausea—Topiramate—epilepsy syndrome	3.27e-06	2.64e-05	CcSEcCtD
Citalopram—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	1.85e-06	4.52e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.84e-06	4.5e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	1.84e-06	4.49e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.83e-06	4.49e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.83e-06	4.49e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.83e-06	4.48e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.82e-06	4.46e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.82e-06	4.46e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	1.81e-06	4.44e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	1.8e-06	4.42e-05	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.8e-06	4.4e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	1.8e-06	4.4e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.79e-06	4.38e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.79e-06	4.37e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.78e-06	4.35e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.77e-06	4.34e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	1.76e-06	4.32e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	1.76e-06	4.3e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	1.76e-06	4.3e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.75e-06	4.28e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.74e-06	4.26e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.74e-06	4.26e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.74e-06	4.25e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	1.73e-06	4.24e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.72e-06	4.21e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.72e-06	4.2e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.72e-06	4.2e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.72e-06	4.2e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.71e-06	4.19e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	1.71e-06	4.18e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.7e-06	4.16e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	1.7e-06	4.15e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.69e-06	4.14e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.69e-06	4.13e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.69e-06	4.12e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.68e-06	4.11e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	1.68e-06	4.1e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.67e-06	4.1e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.66e-06	4.07e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.66e-06	4.06e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.66e-06	4.06e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	1.66e-06	4.06e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.65e-06	4.04e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.65e-06	4.03e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.63e-06	3.99e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	1.63e-06	3.99e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.63e-06	3.98e-05	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.62e-06	3.97e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.62e-06	3.96e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.61e-06	3.95e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.61e-06	3.95e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.6e-06	3.91e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.58e-06	3.86e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.57e-06	3.85e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	1.57e-06	3.84e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.56e-06	3.81e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.55e-06	3.8e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TH—epilepsy syndrome	1.55e-06	3.8e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.54e-06	3.78e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.54e-06	3.76e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.53e-06	3.75e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.53e-06	3.74e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.53e-06	3.74e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.53e-06	3.73e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	1.52e-06	3.73e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.52e-06	3.73e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.52e-06	3.72e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.52e-06	3.72e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.52e-06	3.72e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.52e-06	3.72e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.52e-06	3.71e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.52e-06	3.71e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TH—epilepsy syndrome	1.52e-06	3.71e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.52e-06	3.71e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.51e-06	3.7e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.5e-06	3.68e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.5e-06	3.67e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.5e-06	3.67e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.5e-06	3.66e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.49e-06	3.66e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.49e-06	3.65e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.48e-06	3.63e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.47e-06	3.6e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.47e-06	3.6e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.47e-06	3.6e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.47e-06	3.59e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.45e-06	3.56e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.45e-06	3.56e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.45e-06	3.55e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	1.45e-06	3.55e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.44e-06	3.53e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.43e-06	3.51e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TH—epilepsy syndrome	1.43e-06	3.5e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.43e-06	3.49e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.41e-06	3.46e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.41e-06	3.45e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.4e-06	3.43e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.39e-06	3.41e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.39e-06	3.4e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.38e-06	3.39e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.38e-06	3.38e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.36e-06	3.33e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.36e-06	3.32e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.36e-06	3.32e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.34e-06	3.28e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.31e-06	3.22e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.31e-06	3.22e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.31e-06	3.22e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.31e-06	3.21e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.31e-06	3.21e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	1.31e-06	3.2e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.3e-06	3.17e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.29e-06	3.16e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.29e-06	3.16e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.29e-06	3.15e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.29e-06	3.15e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.29e-06	3.15e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.29e-06	3.15e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	1.28e-06	3.14e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.28e-06	3.13e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.28e-06	3.12e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.27e-06	3.1e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.26e-06	3.09e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.26e-06	3.08e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	1.26e-06	3.07e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CAT—epilepsy syndrome	1.25e-06	3.05e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.25e-06	3.05e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.24e-06	3.04e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.24e-06	3.03e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.23e-06	3e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.21e-06	2.97e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.21e-06	2.97e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TH—epilepsy syndrome	1.21e-06	2.96e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.21e-06	2.96e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.21e-06	2.96e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.2e-06	2.95e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.2e-06	2.93e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.19e-06	2.92e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.19e-06	2.92e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.19e-06	2.91e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.19e-06	2.9e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.18e-06	2.88e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.17e-06	2.86e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.16e-06	2.84e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.16e-06	2.83e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.14e-06	2.8e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.13e-06	2.76e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.13e-06	2.76e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.13e-06	2.76e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.11e-06	2.71e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1.11e-06	2.7e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	1.1e-06	2.7e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.08e-06	2.65e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	1.08e-06	2.65e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.08e-06	2.64e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.06e-06	2.6e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.06e-06	2.6e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.05e-06	2.56e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.05e-06	2.56e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.03e-06	2.52e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.03e-06	2.51e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.01e-06	2.48e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.01e-06	2.47e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.01e-06	2.47e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	9.97e-07	2.44e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CAT—epilepsy syndrome	9.96e-07	2.44e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOE—epilepsy syndrome	9.94e-07	2.43e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—BCHE—epilepsy syndrome	9.93e-07	2.43e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AGT—epilepsy syndrome	9.9e-07	2.42e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	9.77e-07	2.39e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	9.74e-07	2.38e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOE—epilepsy syndrome	9.7e-07	2.37e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	9.69e-07	2.37e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	9.59e-07	2.35e-05	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	9.53e-07	2.33e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.48e-07	2.32e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	9.44e-07	2.31e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.37e-07	2.29e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TH—epilepsy syndrome	9.34e-07	2.29e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.33e-07	2.28e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	9.17e-07	2.24e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOE—epilepsy syndrome	9.14e-07	2.24e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RELA—epilepsy syndrome	9.07e-07	2.22e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	9.04e-07	2.21e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX1—epilepsy syndrome	9.01e-07	2.21e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	9.01e-07	2.21e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	8.92e-07	2.18e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	8.9e-07	2.18e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	8.9e-07	2.18e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	8.87e-07	2.17e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	8.83e-07	2.16e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	8.73e-07	2.14e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	8.65e-07	2.12e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—epilepsy syndrome	8.54e-07	2.09e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—epilepsy syndrome	8.33e-07	2.04e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.26e-07	2.02e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.23e-07	2.01e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	8.23e-07	2.01e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	8.18e-07	2e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	8.16e-07	2e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.1e-07	1.98e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	8.03e-07	1.96e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	8.01e-07	1.96e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—JUN—epilepsy syndrome	7.95e-07	1.94e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	7.92e-07	1.94e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AGT—epilepsy syndrome	7.9e-07	1.93e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—epilepsy syndrome	7.85e-07	1.92e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	7.8e-07	1.91e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.79e-07	1.91e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—epilepsy syndrome	7.78e-07	1.9e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOE—epilepsy syndrome	7.74e-07	1.89e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	7.73e-07	1.89e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	7.71e-07	1.89e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.69e-07	1.88e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—epilepsy syndrome	7.6e-07	1.86e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	7.59e-07	1.86e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	7.5e-07	1.84e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.48e-07	1.83e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	7.47e-07	1.83e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	7.36e-07	1.8e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—epilepsy syndrome	7.16e-07	1.75e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SRC—epilepsy syndrome	7.13e-07	1.74e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	7.11e-07	1.74e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	6.99e-07	1.71e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.96e-07	1.7e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	6.94e-07	1.7e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	6.92e-07	1.69e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	6.81e-07	1.67e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	6.81e-07	1.67e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—epilepsy syndrome	6.65e-07	1.63e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—epilepsy syndrome	6.65e-07	1.63e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.26e-07	1.53e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.1e-07	1.49e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—epilepsy syndrome	6.06e-07	1.48e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.98e-07	1.46e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	5.31e-07	1.3e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.13e-07	1.26e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	5.11e-07	1.25e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.68e-07	1.15e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AKT1—epilepsy syndrome	4.53e-07	1.11e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AKT1—epilepsy syndrome	4.44e-07	1.09e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	4.43e-07	1.08e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	4.42e-07	1.08e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	4.35e-07	1.06e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.09e-07	1e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.42e-07	8.37e-06	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.34e-07	8.17e-06	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.15e-07	7.7e-06	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.67e-07	6.53e-06	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.06e-07	5.04e-06	CbGpPWpGaD
